Abstract:Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease associated with dysfunction of pulmonary artery endothelial cells and pulmonary artery smooth muscle cells (PASMCs). To explore the potential mechanism of miR-193-3p in pulmonary arterial hypertension, human PASMCs and rats were respectively stimulated by hypoxia and monocrotaline to establish PAH model in vivo and in vitro. The expressions of miR-193-3p and p21-activated protein kinase 4 (PAK4) in the lung samples of PAH patients and paired healthy samples from the healthy subjects in PHA cells and rats were detected by quantitative reverse transcriptase-PCR. Morphological changes in lung tissues were determined using hematoxylin and eosin staining. Right ventricular systolic pressure (RVSP) and ratio of right ventricle to left ventricle plus septum (RV/LV p S) were measured. The binding relationship between miR-193-3p and PAK4 was analyzed by TargetScan and verified by luciferase reporter assay. Cell viability, apoptosis, and migration were detected by 3-(4, 5-Dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) flow cytometry, and wound-healing assays, respectively. The protein expressions of PAK4, proliferating cell nuclear antigen (PCNA), P21, p-AKT, and AKT in vivo or in vitro were determined by Western blot. In this study, we found that in pulmonary arterial hypertension, miR-193-3p expression was downregulated and PAK4 expression was up-regulated. MiR-193-3p directly targeted PAK4 and negatively regulated its expression. Hypoxia condition promoted cell proliferation, migration, and inhibited apoptosis accompanied with increased expressions of PCNA and p-AKT/AKT and decreased expression of P21 in PASMCs. MiR-193-3p overexpression attenuated the effects of hypoxia on PASMCs via downregulating PAK4. Monocrotaline treatment increased p-AKT/AKT and decreased P21 expression and caused pulmonary vascular remodeling in the model rats. MiR-193-3p overexpression attenuated pulmonary vascular remodeling, decreased p-AKT/AKT, and increased P21 levels via downregulating PAK4 in monocrotaline-induced rats. The results in this study demonstrated that upregulation of miR-193-3p reduced cell proliferation, migration, and apoptosis of PAH in vitro and pulmonary vascular remodeling in PAH in vivo through downregulating PAK4.

MicroRNA-103/107 is Involved in Hypoxia-Induced Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting HIF-1β

MiRNA Let-7B Promotes the Development of Hypoxic Pulmonary Hypertension by Targeting ACE2.

Increased Expression of MicroRNA‐206 Inhibits Potassium Voltage‐Gated Channel Subfamily A Member 5 in Pulmonary Arterial Smooth Muscle Cells and is Related to Exaggerated Pulmonary Artery Hypertension Following Intrauterine Growth Retardation in Rats

Upregulation of microRNA-17-5p contributes to hypoxia-induced proliferation in human pulmonary artery smooth muscle cells through modulation of p21 and PTEN

MicroRNA-137 Inhibited Hypoxia-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells by Targeting Calpain-2.

MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1|[alpha]||[sol]|Fhl-1 pathway

MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1 α /Fhl-1 pathway

Hypoxia Inducible Factor-1 Mediates Expression Of Mir-322: Potential Role In Proliferation And Migration Of Pulmonary Arterial Smooth Muscle Cells

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

MicroRNA-150 Attenuates Hypoxia-Induced Excessive Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells Through Reducing HIF-1α Expression

miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation

Mir-100 Suppresses Mtor Signaling in Hypoxia-Induced Pulmonary Hypertension in Rats

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

miR-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

MiR-193-3p Attenuates the Vascular Remodeling in Pulmonary Arterial Hypertension by Targeting PAK4

Dysregulation Of Microrna-214 And Pten Contributes To The Pathogenesis Of Hypoxic Pulmonary Hypertension

Anti‐apoptosis endothelial cell‐secreted microRNA‐195‐5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension

MiR-122-5p As a Potential Regulator of Pulmonary Vascular Wall Cell in Idiopathic Pulmonary Arterial Hypertension

Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2

MicroRNA-663 Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension by Targeting TGF-β1/smad2/3 Signaling

The HIF-1 alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy